Hariom Pipe Industries Regulatory Approval

Hariom Pipe Industries Board Meeting Date

Hariom Pipe Industries Limited has intimated a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window closes from 1 October 2026 until 6 November 2026.

Hariom Pipe Industries Partnership

Hariom Pipe signed a non-binding MoU with APEDB for a proposed Rs 700 crore integrated steel plant in Andhra Pradesh. Implementation remains subject to approvals and clearances.

Value

₹700.0 Cr

Hariom Pipe Industries Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine compliance disclosure under Regulation 31(1)(b).

Hariom Pipe Industries Production Started

Hariom Pipe Industries' subsidiary commissioned two solar power plants with a cumulative capacity of 10 MW (AC) in Maharashtra. This adds to the Group's renewable capacity.

solar power generation capacity

10.0 MW

Hariom Pipe Industries Other Announcement

The company filed its quarterly compliance certificate under SEBI Regulation 74(5) from its RTA, confirming that all shares are held in dematerialized form.

Hariom Pipe Industries Annual General Meeting

Hariom Pipe Industries Limited conducted its 19th Annual General Meeting on September 30, 2026. The proceedings covered financial adoption, director re-appointments, and dividend approval.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution

Three years from the date of taking charge

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution

Valid up to March 30, 2031